Wyeth Under Investigation for Off-Label Rapamune Promotion

Drug Industry Daily
A A
A House committee is looking into reports that Wyeth promoted kidney transplant drug Rapamune for off-label uses, particularly to African-Americans.

To View This Article:

Login

Subscribe To Drug Industry Daily